Goldman Sachs Group »

Kiniksa Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $16M 909k 17.54
2023-09-30 $15M 866k 17.37
2023-06-30 $5.2M 372k 14.08
2023-03-31 $4.5M 422k 10.76
2022-12-31 $15M 1.0M 14.98
2022-06-30 $6.1M 634k 9.69
2022-03-31 $9.3M 937k 9.94
2021-12-31 $6.8M 579k 11.77
2021-09-30 $5.6M 490k 11.39
2021-03-31 $7.9M 425k 18.51
2020-12-31 $9.9M 559k 17.67
2020-09-30 $1.8M 114k 15.32
2020-06-30 $2.1M 84k 25.49
2019-12-31 $150k 14k 11.08
2019-09-30 $499k 59k 8.51
2019-06-30 $190k 14k 13.54
2019-03-31 $315k 18k 18.03
2018-06-30 $1.6M 90k 17.35